Prostaglandin E2 after septostomy for simple transposition

Area of Science:

• Pediatric Cardiology
• Congenital Heart Disease Surgery
• Neonatal Intensive Care

Background:

• Simple transposition of the great arteries (sTGA) requires interventions to improve systemic and pulmonary circulation mixing.
• Balloon atrial septostomy is a common procedure, often followed by prostaglandin E2 (PGE2) administration.
• The impact of postoperative PGE2 on outcomes in sTGA patients is not fully understood.

Purpose of the Study:

• To determine the frequency of PGE2 use after septostomy in sTGA infants.
• To identify indications for initiating PGE2 post-septostomy.
• To evaluate the effect of PGE2 on postoperative outcomes.

Main Methods:

• Retrospective review of 26 infants with sTGA undergoing arterial switch between 2000-2005.
• Categorization of patients based on PGE2 administration timing (pre/post-septostomy).
• Comparison of postoperative outcomes (oxygen saturation, length of stay) between groups.

Main Results:

• 54% of infants received PGE2 following septostomy.
• PGE2 administration post-septostomy was linked to lower oxygen saturation at arterial switch.
• Patients receiving PGE2 post-septostomy experienced longer Intensive Care Unit (ICU) and total postoperative stays.

Conclusions:

• Increased use of PGE2 post-septostomy, potentially due to pulse oximetry monitoring.
• PGE2 administration is associated with prolonged ICU and postoperative recovery periods.
• Early surgical repair with minimized preoperative medical management, including PGE2, is supported.